Cytori Announces Progress in Cardiac Regeneration Clinical Studies

Posted on February 1, 2008 by jrowley

Cytori Therapeutics announced that they have enrolled their first two patients in an acute myocardial infarction clinical trial using adipose-derived cells prepared using their Celution™ device. The Celution™ device is an automated, tissue processing unit that isolates cells from adipose tissue derived via liposuction.

Filed under: adult stem cell, autologous, Bioprocessing, cardiac regeneration, cell delivery, Clinical Trials, Company Profiles, Cytori, Device-centric cell therapies, patient specific cell therapy, personalized medicine, Regenerative Medicine, stem cells | Leave a Comment »

Athersys’ Adult Stem Cell Product IND Approved for Acute MI Phase I Trial

Posted on December 23, 2007 by jrowley

Athersys and their cardiac parter, Angiotech, announced today that they got the ok from the FDA to begin a Phase I clinical study using Athersys’ Multistem adult stem cell product in acute myocardial infarction (MI). This is the second IND approval for Athersys in just over a month (and a welcome Christmas present for the [...]

Filed under: Angiotech, Athersys, Biomaterials, cardiac regeneration, cell delivery, Clinical Trials, Joint Ventures, Regenerative Medicine | Tagged: , , , , | Leave a Comment »

CellCyte Issued Patent for Enhancing Cell Delivery to Cardiac Tissue

Posted on November 26, 2007 by jrowley

CellCyte Genetics Corporation recently announced that US Patent No 7,282,222 was issued, a patent which they have exclusive rights to. The press release states that the patent covers unique methods and compositions “to deliver and direct stem cells to target organs in the body”, including cardiac tissue. The focus of the patent addresses cell retention [...]

Filed under: cardiac regeneration, cell delivery, Clinical Trials, Intellectual Property, Regenerative Medicine, stem cells | 1 Comment »

  • Subscribe via email

    Subscribe to The Regeneration Station by Email

  • Top Posts

  • a

Follow

Get every new post delivered to your Inbox.